Providers in some states may soon discover a big hurdle to clear when seeking to report a set of apheresis services after one Medicare administrative contractor tightened up physician supervision requirements.
Beginning or expanding a remote CDI program requires planning, and it might not be for everyone. But, with the right preparation, organizations can make the transition beneficial to all.
The fiscal year 2018 IPPS final rule included updates to payment rates and quality initiatives, as well as an ample amount of code changes and updates to ICD-10-PCS non-OR to OR code designations.
Q: If a patient is admitted for anemia related to a malignancy and is treated only for anemia, the principal diagnosis goes to the malignancy. Could you still code for the malignancy as the principal diagnosis if the patient was treated for other conditions at the same time?
James S. Kennedy, MD, CCS, CCDS, CDIP, details how Coding Clinic , Second Quarter 2017, did not disappoint in addressing clinical issues affecting those in coding compliance and instructing how to properly use the ICD-10-CM Index and Table .
CMS recently released the 2018 IPPS final rule, with updates to various quality initiatives, annual payment updates for inpatient services, and an extensive amount of now-annual ICD-10-PCS code additions, deletions, and revisions. This article reviews guideline updates, the addition of “other devices” characters, and new tables added for root operation Replacement. Note: To access this free article, make sure you first register here if you do not have a paid subscription.
Providers in some states may soon discover a big hurdle to clear when seeking to report a set of apheresis services after one MAC tightened up physician supervision requirements.
The new ICD-10-CM codes for FY 2018, effective October 1, represent significant changes in our documentation and coding practices. Let’s discuss some of these new codes and their potential impact upon your diagnostic decision-making and documentation.
In the 2018 OPPS proposed rule, CMS proposed a change to the current clinical laboratory date-of-service policies for molecular pathology tests and for Advanced Diagnostic Laboratory Tests.
